The 1-Month Treasury may or may not decrease around 2024-01 to 2026-01.
$133 to $140 on 30m chart 2023-12 to 2024-02 1-day Chart ( click to play ): NASDAQ:GOOGL potentially reaching $133-$140 within the next three weeks or as high as $141-$143 if there is any new news on advancements (or partnerships). The Elliott Wave Principle suggests a potential bullish continuation within a larger Wave 3. A breakout above $133.34 could...
NASDAQ:GOOGL potentially reaching $141-$143 within the next three weeks or as high as potentially reaching $141-$143 within the next three weeks if there is any new news on advancements (or partnerships). The Elliott Wave Principle suggests a potential bullish continuation within a larger Wave 3. A breakout above $133.34 could propel the stock towards...
X may peak around the $44 to $49 price zone by 2023-08, then decline to the $23 to $28 price zone for the 2023 bottom. The end of 2023 may see a return to the $36 to $46 price zone. Please share your charts in the comments section below. I would really like to see more X forecasts for 2023 .
SLX may peak around the $69 to $79 price zone by 2023-08, then decline to the $51 to $61 price zone for the 2023 bottom. The end of 2023 may see a return to the $61 to $71 price zone. Please share your charts in the comments section below. I would really like to see more SLX forecasts for 2023.
This is a 4-hour BTC 2023-03 forecast with: BTC dominance & USDT dominance at the base of the chart. Further below are the top largest four crypto TOTAL market caps.
PAXGUSD may dip near 1960.00 during 2023-05, then increase by 2023-07.
This alternative view of the BTC halving cycles contains estimated peaks and lows. This view may be easier to see. Please let me know if you have any questions or ideas.
This is a daily view of an alternative path that reflects a green path near $32666 to $36666, followed by a downtrend to near the $19666 zone. This is in addition to the blue & pink lines reflecting a bottom near the $14666 to $17666 zones (around 2023-06-06 plus or minus 1-month).
This is an analysis of the US "3-month Treasury" versus the "10-Year Treasury". This is monitored by some analysts that are looking for potential "Inverted Yield Curves". It may be best not to explain the detailed reasoning, but one can always research the "possible" expected results from the correlation between the two and the phrase "Inverted Yield Curve". At...
1-Month Treasury Constant (FRED-DGS1MO) Measured in CFDs on Gold (US$ / OZ) Analysis for the Past 30 Days Overview The 1-Month Treasury Constant (FRED-DGS1MO), measured in CFDs on Gold (US$ / OZ), has exhibited a downward trend over the past 30 days. This indicates that the implied interest rate for holding Gold futures contracts for one month has...
Perhaps OREAF (a Gold exploration & acquisition mining company that uses some green-energy like hydrogen fuel cells & solar ; along with ground-penetrating drone-mapping technology to target key deposits) may continue increasing through Q1 2026 . PHO (fresh water) & WEAT ( wheat ) are at the base measuring in % gains to compare to the gains of OREAF...
Merck & Co. (MRK) - signs of potential breakout 4-hour Merck is a large pharmaceutical company that develops and sells vaccines, including a vaccine for pneumonia. The company's stock is undervalued, and it is starting to show signs of a breakout. The stock is up over 8% in the past month, and it is trading above its 50-day moving average. Merck & Co....
Pfizer (PFE) - signs of potential breakout 4-hour Pfizer is a large pharmaceutical company that develops and sells vaccines, including a vaccine for pneumonia. The company's stock is undervalued, and it is starting to show signs of a breakout. The stock is up over 10% in the past month, and it is trading above its 50-day moving average. Pfizer (PFE) Stock...
Novavax (NVAX) - signs of potential breakout 4-hour Novavax is a clinical-stage biotechnology company developing a vaccine for influenza. The company's stock has been undervalued for some time, but it is starting to show signs of a breakout. The stock is up over 40% in the past month, and it is trading above its 50-day and 200-day moving averages. ...
Vaxart (VXRT) - signs of potential breakout 4-hour Vaxart is a clinical-stage biotechnology company developing a tablet-based vaccine for pneumonia. The company's stock has been undervalued for some time, but it is starting to show signs of a breakout. The stock is up over 30% in the past month, and it is trading above its 50-day moving average. Overview...
Emergent Biosolutions (EBS) - signs of potential breakout Emergent Biosolutions (EBS): EBS is a clinical-stage biotechnology company developing a novel vaccine for pneumonia. The company's stock has been undervalued for some time, but it is starting to show signs of a breakout. The stock is up over 20% in the past month, and it is trading above its 50-day...
Possible Pneumonia Stocks - signs of potential breakout Emergent Biosolutions (EBS) : EBS is a clinical-stage biotechnology company developing a novel vaccine for pneumonia. The company's stock has been undervalued for some time, but it is starting to show signs of a breakout . The stock is up over 20% in the past month , and it is trading above its...